Skip to main content
Top
Published in: Journal of Anesthesia 6/2019

Open Access 01-12-2019 | Septicemia | Editorial

Post-surgical immune suppression: another target to improve postoperative outcomes

Author: Kanji Uchida

Published in: Journal of Anesthesia | Issue 6/2019

Login to get access

Excerpt

Patients undergoing surgery suffer from “scheduled insult”. In general, surgical insult causes local inflammation via migrating inflammatory cells. Local inflammation is accompanied by systemic inflammatory responses characterized by fever and elevated levels of systemic inflammatory cytokines. In most cases, inflammation eventually subsides, which leads to wound healing. However, for those with severe inflammation it sometimes progresses to sepsis and multiple organ dysfunction syndrome (MODS). …
Literature
1.
go back to reference Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R. Surviving sepsis campaign guidelines committee including the pediatric subgroup: surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165–228.CrossRef Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R. Surviving sepsis campaign guidelines committee including the pediatric subgroup: surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165–228.CrossRef
2.
go back to reference Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840–51.CrossRef Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840–51.CrossRef
3.
go back to reference Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol. 2011;6:147–63.CrossRef Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol. 2011;6:147–63.CrossRef
4.
go back to reference Talmor M, Hydo L, Barie PS. Relationship of systemic inflammatory response syndrome to organ dysfunction, length of stay, and mortality in critical surgical illness: effect of intensive care unit resuscitation. Arch Surg. 1999;134(1):81–7.CrossRef Talmor M, Hydo L, Barie PS. Relationship of systemic inflammatory response syndrome to organ dysfunction, length of stay, and mortality in critical surgical illness: effect of intensive care unit resuscitation. Arch Surg. 1999;134(1):81–7.CrossRef
5.
go back to reference Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, Wittebole X, Dugernier T, Perrotin D, Tidswell M, Jauregui L, Krell K, Pachl J, Takahashi T, Peckelsen C, Cordasco E, Chang CS, Oeyen S, Aikawa N, Maruyama T, Schein R, Kalil AC, Van Nuffelen M, Lynn M, Rossignol DP, Gogate J, Roberts MB, Wheeler JL, Vincent JL, ACCESS Study Group. Effect of Eritoran, an Antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA. 2013;309(11):1154–62.CrossRef Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, Wittebole X, Dugernier T, Perrotin D, Tidswell M, Jauregui L, Krell K, Pachl J, Takahashi T, Peckelsen C, Cordasco E, Chang CS, Oeyen S, Aikawa N, Maruyama T, Schein R, Kalil AC, Van Nuffelen M, Lynn M, Rossignol DP, Gogate J, Roberts MB, Wheeler JL, Vincent JL, ACCESS Study Group. Effect of Eritoran, an Antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA. 2013;309(11):1154–62.CrossRef
6.
go back to reference Marshall JC. Why have clinical trials in sepsis failed? Trends Mol Med. 2014;20:195–203.CrossRef Marshall JC. Why have clinical trials in sepsis failed? Trends Mol Med. 2014;20:195–203.CrossRef
7.
go back to reference Duggal A, Ganapathy A, Ratnapalan M, Adhikari NKJ. Pharmacological treatments for acute respiratory distress syndrome: systematic review. Minerva Anestesiol. 2015;81(5):567–88.PubMed Duggal A, Ganapathy A, Ratnapalan M, Adhikari NKJ. Pharmacological treatments for acute respiratory distress syndrome: systematic review. Minerva Anestesiol. 2015;81(5):567–88.PubMed
8.
go back to reference Kido T, Muramatsu K, Asakawa T, Otsubo H, Ogoshi T, Oda K, Kubo T, Fujino Y, Matsuda S, Mayumi T, Mukae H, Yatera K. The relationship between high-dose corticosteroid treatment and mortality in acute respiratory distress syndrome: a retrospective and observational study using a nationwide administrative database in Japan. BMC Pulm Med. 2018;18(1):28. https://doi.org/10.1186/s12890-018-0597-5.CrossRefPubMedPubMedCentral Kido T, Muramatsu K, Asakawa T, Otsubo H, Ogoshi T, Oda K, Kubo T, Fujino Y, Matsuda S, Mayumi T, Mukae H, Yatera K. The relationship between high-dose corticosteroid treatment and mortality in acute respiratory distress syndrome: a retrospective and observational study using a nationwide administrative database in Japan. BMC Pulm Med. 2018;18(1):28. https://​doi.​org/​10.​1186/​s12890-018-0597-5.CrossRefPubMedPubMedCentral
9.
go back to reference Miwa Kishimoto M, Yamana H, Inoue S, Noda T, Myojin T, Matsui H, Yasunaga H, Kawaguchi M, Imamura T. Sivelestat sodium and mortality in pneumonia patients requiring mechanical ventilation: propensity score analysis of a Japanese nationwide database. J Anesth. 2017;31:405–12.CrossRef Miwa Kishimoto M, Yamana H, Inoue S, Noda T, Myojin T, Matsui H, Yasunaga H, Kawaguchi M, Imamura T. Sivelestat sodium and mortality in pneumonia patients requiring mechanical ventilation: propensity score analysis of a Japanese nationwide database. J Anesth. 2017;31:405–12.CrossRef
10.
go back to reference Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA. The sepsis seesaw: tilting toward immunosuppression. Nat Med. 2009;15(5):496–7.CrossRef Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA. The sepsis seesaw: tilting toward immunosuppression. Nat Med. 2009;15(5):496–7.CrossRef
11.
go back to reference Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862–74.CrossRef Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862–74.CrossRef
12.
go back to reference Dąbrowska AM, Słotwiński R. The immune response to surgery and infection. Cent Eur J Immunol. 2014;39(4):532–7.CrossRef Dąbrowska AM, Słotwiński R. The immune response to surgery and infection. Cent Eur J Immunol. 2014;39(4):532–7.CrossRef
13.
go back to reference Wang H, Bloom O, Zhang M, Jaideep M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285(5425):248–51.CrossRef Wang H, Bloom O, Zhang M, Jaideep M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285(5425):248–51.CrossRef
14.
go back to reference MacFie J. Current status of bacterial translocation as a cause of surgical sepsis. Br Med Bull. 2004;13(71):1–11. MacFie J. Current status of bacterial translocation as a cause of surgical sepsis. Br Med Bull. 2004;13(71):1–11.
15.
go back to reference Vallejo MC, Attaallah AF, Shapiro RE, Elzamzamy OM, Mueller MG, Eller WS. Independent risk factors for surgical site infection after cesarean delivery in a rural tertiary care medical center. J Anesth. 2017;31(1):120–6.CrossRef Vallejo MC, Attaallah AF, Shapiro RE, Elzamzamy OM, Mueller MG, Eller WS. Independent risk factors for surgical site infection after cesarean delivery in a rural tertiary care medical center. J Anesth. 2017;31(1):120–6.CrossRef
16.
go back to reference Liu S, Miao J, Wang G, Wang M, Wu X, Guo K, Feng M, Guan W, Ren J. Risk factors for postoperative surgical site infections in patients with Crohn’s disease receiving definitive bowel resection. Sci Rep. 2017;7:9828.CrossRef Liu S, Miao J, Wang G, Wang M, Wu X, Guo K, Feng M, Guan W, Ren J. Risk factors for postoperative surgical site infections in patients with Crohn’s disease receiving definitive bowel resection. Sci Rep. 2017;7:9828.CrossRef
17.
go back to reference Hiruma T, Tsuyuzaki H, Uchida K, Trapnell BC, Yamamura Y, Kusakabe Y, Totsu T, Suzuki T, Morita S, Doi K, Noiri E, Nakamura K, Nakajima S, Yahagi N, Morimura N, Chang K, Yamada Y. IFN-β improves sepsis-related alveolar macrophage dysfunction and postseptic acute respiratory distress syndrome-related mortality. Am J Respir Cell Mol Biol. 2018;59(1):45–55.CrossRef Hiruma T, Tsuyuzaki H, Uchida K, Trapnell BC, Yamamura Y, Kusakabe Y, Totsu T, Suzuki T, Morita S, Doi K, Noiri E, Nakamura K, Nakajima S, Yahagi N, Morimura N, Chang K, Yamada Y. IFN-β improves sepsis-related alveolar macrophage dysfunction and postseptic acute respiratory distress syndrome-related mortality. Am J Respir Cell Mol Biol. 2018;59(1):45–55.CrossRef
18.
go back to reference Kusakabe Y, Uchida K, Yamamura Y, Hiruma T, Totsu T, Tamai Y, Tsuyuzaki H, Hasegawa K, Chang K, Yamada Y. Early-phase innate immune suppression in murine severe sepsis is restored with systemic interferon-β. Anesthesiology. 2018;129(1):131–42.CrossRef Kusakabe Y, Uchida K, Yamamura Y, Hiruma T, Totsu T, Tamai Y, Tsuyuzaki H, Hasegawa K, Chang K, Yamada Y. Early-phase innate immune suppression in murine severe sepsis is restored with systemic interferon-β. Anesthesiology. 2018;129(1):131–42.CrossRef
19.
go back to reference Almansa R, Martín S, Martin-Fernandez M, Heredia-Rodríguez M, Gómez-Sánchez E, Aragón M, Andrés C, Calvo D, Rico-Feijoo J, Esteban-Velasco MC, Vaquero-Roncero LM, Ortega A, Gómez-Pesquera E, Lorenzo-López M, de Cenarruzabeitia IL, Benavides D, López-Sanchez J, Doncel C, González-Sanchez C, Zarca E, Ríos-Llorente A, Diaz A, Sanchez-Barrado E, de Heredia JB, Calvo-Vecino JM, Muñoz-Bellvís L, Gomez-Herreras JI, Aldecoa C, Tamayo E, Bermejo-Martin JF. Combined quantification of procalcitonin and HLA-DR improves sepsis detection in surgical patients. Sci Rep. 2018;8(1):11999.CrossRef Almansa R, Martín S, Martin-Fernandez M, Heredia-Rodríguez M, Gómez-Sánchez E, Aragón M, Andrés C, Calvo D, Rico-Feijoo J, Esteban-Velasco MC, Vaquero-Roncero LM, Ortega A, Gómez-Pesquera E, Lorenzo-López M, de Cenarruzabeitia IL, Benavides D, López-Sanchez J, Doncel C, González-Sanchez C, Zarca E, Ríos-Llorente A, Diaz A, Sanchez-Barrado E, de Heredia JB, Calvo-Vecino JM, Muñoz-Bellvís L, Gomez-Herreras JI, Aldecoa C, Tamayo E, Bermejo-Martin JF. Combined quantification of procalcitonin and HLA-DR improves sepsis detection in surgical patients. Sci Rep. 2018;8(1):11999.CrossRef
Metadata
Title
Post-surgical immune suppression: another target to improve postoperative outcomes
Author
Kanji Uchida
Publication date
01-12-2019
Publisher
Springer Japan
Published in
Journal of Anesthesia / Issue 6/2019
Print ISSN: 0913-8668
Electronic ISSN: 1438-8359
DOI
https://doi.org/10.1007/s00540-019-02651-3

Other articles of this Issue 6/2019

Journal of Anesthesia 6/2019 Go to the issue